Overview
The 1998 original publication describes the development and pharmacology of ipamorelin, identifies it as a pentapeptide, and reports growth-hormone release studies in cellular and animal models.
Identity & classification
- NAME
- Ipamorelin
- RESEARCH CATEGORY
- ENDOCRINE RESEARCH
- MOLECULAR CLASS
- Pentapeptide growth-hormone secretagogue
- KEY DISTINCTION
- Distinguish secretagogue research from GHRH-analogue research
Reading the evidence
Keep the experimental model and comparators attached to a cited finding. Receptor and hormone measurements explain the study question; they do not establish an individual-use regimen or the quality of a separate sample.